Emf6.1Fab treatment of hGP6tg/tg mice resulted in profound GPVI inhibition and protection from occlusive arterial thrombosis and thrombo-inflammatory cerebral infarct growth in experimental stroke, while not affecting tail bleeding times, even under conditions of complete receptor blockade (Structured Graphical Abstract ). The gene discussed is GP6; the disease is cerebral infarction.